Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors
Donna Shu‐Han Lin, An‐Li Yu, Hao-Yun Lo, Cheng-Wei Lien, Jen‐Kuang Lee, Wen‐Jone Chen
Topics & Concepts
MedicineMyocardial infarctionDiabetes mellitusStroke (engine)Internal medicineAdverse effectCritical limb ischemiaCardiologyRevascularizationEndocrinologyMechanical engineeringEngineeringDiabetes Treatment and ManagementPeripheral Artery Disease ManagementBariatric Surgery and Outcomes